Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR
Molecular Metabolism2018Vol. 9, pp. 131–140
Citations Over TimeTop 10% of 2018 papers
Kavita Jadhav, Yang Xu, Yanyong Xu, Yuanyuan Li, Jiesi Xu, Yingdong Zhu, Luciano Adorini, Yoon Kwang Lee, Takhar Kasumov, Liya Yin, Yanqiao Zhang
Abstract
BA receptor activation can reverse obesity, NAFLD, and atherosclerosis by specific activation of FXR or TGR5. Our data suggest that, compared to activation of FXR or TGR5 only, dual activation of both FXR and TGR5 is a more attractive strategy for treatment of common metabolic disorders.
Related Papers
- → Bile acid metabolism and signaling in liver disease and therapy(2017)288 cited
- → Bile Acid Metabolism and the Pathogenesis of Type 2 Diabetes(2011)235 cited
- → Modulating bile acid pathways and TGR5 receptors for treating liver and GI diseases(2017)51 cited
- → Metabolic effects of bile acid sequestration(2016)10 cited
- → Bile acid metabolism and type 2 diabetes(2014)